Accenture's Stock Climbs 1.09% on Healthcare Tech Surge Despite 121st Trading Rank and 21.54% Volume Drop

Accenture (ACN) rose 1.09% on October 13, 2025, with a trading volume of $0.87 billion, representing a 21.54% decline from the previous day. The stock ranked 121st in trading activity among listed equities. The movement followed reports of renewed demand for digital transformation services in the healthcare sector, where the firm secured a multi-year partnership to modernize data infrastructure for three major hospital networks.

Analysts noted that the stock’s performance was partially driven by positive sentiment around its Q3 earnings outlook, with recent client retention rates exceeding 95% in high-margin consulting divisions. However, muted volume suggests limited follow-through from institutional investors, as no major hedge fund disclosures were reported in the prior week. The firm’s guidance on AI integration costs for 2026 also remained unchanged, aligning with market expectations.

Below is an interactive report of the requested back-test. Key take-aways: the “RSI-oversold, 1-day hold” filter produced a positive but moderate annualised return and a draw-down that remains contained; however, the hit-rate was low and most gains were driven by a handful of strong rebounds, so the strategy is sensitive to entry timing.